Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Iovance Biotherapeutics (IOVA) Shares Outstanding (Weighted Average) (2016 - 2025)

Iovance Biotherapeutics has reported Shares Outstanding (Weighted Average) over the past 13 years, most recently at $357345.0 for Q4 2025.

  • Quarterly results put Shares Outstanding (Weighted Average) at $357345.0 for Q4 2025, up 23.27% from a year ago — trailing twelve months through Dec 2025 was $357345.0 (up 23.27% YoY), and the annual figure for FY2025 was $357345.0, up 23.27%.
  • Shares Outstanding (Weighted Average) for Q4 2025 was $357345.0 at Iovance Biotherapeutics, down from $364037.0 in the prior quarter.
  • Over the last five years, Shares Outstanding (Weighted Average) for IOVA hit a ceiling of $213.7 million in Q1 2023 and a floor of $224481.0 in Q2 2023.
  • Median Shares Outstanding (Weighted Average) over the past 3 years was $287356.5 (2024), compared with a mean of $18.1 million.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): crashed 99.88% in 2024 and later grew 27.81% in 2025.
  • Iovance Biotherapeutics' Shares Outstanding (Weighted Average) stood at $235131.0 in 2023, then increased by 23.28% to $289877.0 in 2024, then increased by 23.27% to $357345.0 in 2025.
  • The last three reported values for Shares Outstanding (Weighted Average) were $357345.0 (Q4 2025), $364037.0 (Q3 2025), and $328721.0 (Q2 2025) per Business Quant data.